Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing

被引:18
作者
Livermore, DM
Stephens, P
Weinberg, J
Johnson, AP
Gifford, T
Northcott, D
James, D
George, RC
Speller, DCE
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
[2] IMS Hlth UK, Pinner HA5 5HQ, Middx, England
[3] Publ Hlth Lab Serv Headquarters, London NW9 5HT, England
关键词
D O I
10.1093/jac/46.3.411
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Over 200 hospitals in England report resistance data for bacteraemia and meningitis isolates to the Public Health Laboratory Service. We reviewed ampicillin and trimethoprim resistance rates from 1990 to 1997 for Escherichia coli, which is the species reported most frequently from these bacteraemias. Ampicillin resistance was relatively stable over time, but varied between Health Regions. The proportion of ampicillin-resistant E. coli in the East Anglia region remained less than or equal to 42% in all years except one and that in the South Western region always remained <50%. At the other extreme, the proportions of ampicillin-resistant isolates in the Northern and Trent regions never fell below 59%. The prevalence of resistance to trimethoprim rose over time in most regions; again, however, the prevalence of resistant isolates was lowest in the East Anglia and South Western regions, whereas the highest resistance rates were reported from Mersey, NW Thames, NE Thames and North Western regions. These observations were related to data for community prescribing, which accounts for most ampicillin and trimethoprim use. Prescribing data for ampicillin and trimethoprim from 1987 to 1997 were obtained from the IMS-HEALTH Medical Data Index, and data for all antibacterial drugs between 1995 and 1997 from the Prescription Pricing Authority. Correlations between resistance rates and prescribing of specific antibiotics were weak, although there was some trend for regions with high total prescribing to have higher rates of ampicillin resistance. The South Western region was conspicuous both for low rates of resistance and low prescribing. Several factors may determine the lack of wider and more obvious relationships between resistance and prescribing. In particular, regions may be inappropriately large areas to test the relationship, isolates from bacteraemias may not be representative of those experiencing selection pressure in the community and the resistance data may have been distorted by nosocomial strains, although this seems unlikely with E. coli.
引用
收藏
页码:411 / 422
页数:12
相关论文
共 16 条
[1]   A survey of antimicrobial susceptibility testing in the United Kingdom [J].
Andrews, JM ;
Brown, D ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :187-188
[2]  
[Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1
[3]   Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae [J].
Chiew, YF ;
Yeo, SF ;
Hall, LMC ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (02) :247-251
[4]   RESISTANCE TO TRIMETHOPRIM IN 1978-79 COMPARED WITH 1973-75 [J].
HAMILTONMILLER, JMT ;
GOODING, A ;
BRUMFITT, W .
JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (04) :439-442
[5]   TRIMETHOPRIM RESISTANCE IN FINLAND AFTER 5 YEARS USE OF PLAIN TRIMETHOPRIM [J].
HUOVINEN, P ;
TOIVANEN, P .
BRITISH MEDICAL JOURNAL, 1980, 280 (6207) :72-74
[6]  
Livermore D.M., 1996, ANTIBIOTICS LAB MED, P502
[7]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[8]  
LIVESEY G, 1991, EUR J CLIN NUTR, V45, P1
[9]   Surveillance of antimicrobial resistance [J].
MacGowan, AP ;
BowKer, KE ;
Bennett, PM ;
Lovering, AM .
LANCET, 1998, 352 (9142) :1783-1783
[10]  
Maclaren D. M., 1997, P469